Lacosamide
Brand name: Lacosamide
Rank #173 of 500 drugs by total cost
$90.1M
Total Cost
300,038
Total Claims
$90.1M
Total Cost
7,587
Prescribers
$300
Cost per Claim
26,440
Beneficiaries
364,890
30-Day Fills
$12K
Avg Cost/Provider
40
Avg Claims/Provider
About Lacosamide
Lacosamide (sold as Lacosamide) was prescribed 300,038 times by 7,587 Medicare Part D providers in 2023, costing the program $90.1M. At $300 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 170 | Insulin Glargine/Lixisenatide (Soliqua 100-33) | $92.5M | 82,886 |
| 171 | Latanoprost (Latanoprost) | $92.3M | 4,388,601 |
| 172 | Ribociclib Succinate (Kisqali) | $90.3M | 5,978 |
| 173 | Lacosamide (Lacosamide) | $90.1M | 300,038 |
| 174 | Mepolizumab (Nucala) | $90.1M | 20,798 |
| 175 | Finerenone (Kerendia) | $89.5M | 93,151 |
| 176 | Ixazomib Citrate (Ninlaro) | $89.0M | 6,901 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology